Oceana Therapeutics

Drug development and commercialization for gastroenterology and urological diseases

Oceana was a specialty pharmaceuticals company focusing on inlicensing, developing, and commercializing therapeutics for gastroenterology and urological diseases. The company's portfolio included the following products: 1) Deflux, a commercial-stage bulking agent indicated for treatment of children with vesicoureteral reflux; and 2) Solesta, a biocompatible bulking gel for treatment of fecal incontinence. Oceana received FDA approval for Solesta in 2011, and the company was subsequently acquired by Salix the same year.

Acquired by Salix Pharmaceuticals in 2011
Year of Investment
Life Sciences
Edison, New Jersey